111 related articles for article (PubMed ID: 27780835)
1. Developmental Changes in Hepatic Organic Cation Transporter OCT1 Protein Expression from Neonates to Children.
Hahn D; Emoto C; Vinks AA; Fukuda T
Drug Metab Dispos; 2017 Jan; 45(1):23-26. PubMed ID: 27780835
[TBL] [Abstract][Full Text] [Related]
2. Influence of MRP3 Genetics and Hepatic Expression Ontogeny for Morphine Disposition in Neonatal and Pediatric Patients.
Hahn D; Fukuda T; Euteneuer JC; Mizuno T; Vinks AA; Sadhasivam S; Emoto C
J Clin Pharmacol; 2020 Aug; 60(8):992-998. PubMed ID: 32090339
[TBL] [Abstract][Full Text] [Related]
3. SLC22A1/OCT1 Genotype Affects O-desmethyltramadol Exposure in Newborn Infants.
Matic M; de Wildt SN; Elens L; de Hoon JN; Annaert P; Tibboel D; van Schaik RH; Allegaert K
Ther Drug Monit; 2016 Aug; 38(4):487-92. PubMed ID: 27082504
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of Organic Cation Transporter 1 (OCT1) Substrates in Oct1/2 Knockout Mice and Species Difference in Hepatic OCT1-Mediated Uptake.
Morse BL; Kolur A; Hudson LR; Hogan AT; Chen LH; Brackman RM; Sawada GA; Fallon JK; Smith PC; Hillgren KM
Drug Metab Dispos; 2020 Feb; 48(2):93-105. PubMed ID: 31771949
[TBL] [Abstract][Full Text] [Related]
5. PBPK Model of Morphine Incorporating Developmental Changes in Hepatic OCT1 and UGT2B7 Proteins to Explain the Variability in Clearances in Neonates and Small Infants.
Emoto C; Johnson TN; Neuhoff S; Hahn D; Vinks AA; Fukuda T
CPT Pharmacometrics Syst Pharmacol; 2018 Jul; 7(7):464-473. PubMed ID: 29920988
[TBL] [Abstract][Full Text] [Related]
6. OCT1 mediates hepatic uptake of sumatriptan and loss-of-function OCT1 polymorphisms affect sumatriptan pharmacokinetics.
Matthaei J; Kuron D; Faltraco F; Knoch T; Dos Santos Pereira JN; Abu Abed M; Prukop T; Brockmöller J; Tzvetkov MV
Clin Pharmacol Ther; 2016 Jun; 99(6):633-41. PubMed ID: 26659468
[TBL] [Abstract][Full Text] [Related]
7. Influence of OCT1 Ontogeny and Genetic Variation on Morphine Disposition in Critically Ill Neonates: Lessons From PBPK Modeling and Clinical Study.
Hahn D; Emoto C; Euteneuer JC; Mizuno T; Vinks AA; Fukuda T
Clin Pharmacol Ther; 2019 Mar; 105(3):761-768. PubMed ID: 30300922
[TBL] [Abstract][Full Text] [Related]
8. Variability and Heritability of Thiamine Pharmacokinetics With Focus on OCT1 Effects on Membrane Transport and Pharmacokinetics in Humans.
Jensen O; Matthaei J; Blome F; Schwab M; Tzvetkov MV; Brockmöller J
Clin Pharmacol Ther; 2020 Mar; 107(3):628-638. PubMed ID: 31593619
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Contributing Factors to Variability in Morphine Clearance Through PBPK Modeling Implemented With OCT1 Transporter.
Emoto C; Fukuda T; Johnson TN; Neuhoff S; Sadhasivam S; Vinks AA
CPT Pharmacometrics Syst Pharmacol; 2017 Feb; 6(2):110-119. PubMed ID: 27935268
[TBL] [Abstract][Full Text] [Related]
10. The human organic cation transporter OCT1 and its role as a target for drug responses.
Brosseau N; Ramotar D
Drug Metab Rev; 2019 Nov; 51(4):389-407. PubMed ID: 31564168
[TBL] [Abstract][Full Text] [Related]
11. Inter-Subject Variability in OCT1 Activity in 27 Batches of Cryopreserved Human Hepatocytes and Association with OCT1 mRNA Expression and Genotype.
Fattah S; Shinde AB; Matic M; Baes M; van Schaik RHN; Allegaert K; Parmentier C; Richert L; Augustijns P; Annaert P
Pharm Res; 2017 Jun; 34(6):1309-1319. PubMed ID: 28364304
[TBL] [Abstract][Full Text] [Related]
12. Regulation of basal core promoter activity of human organic cation transporter 1 (OCT1/SLC22A1).
Kajiwara M; Terada T; Asaka J; Aoki M; Katsura T; Ikai I; Inui K
Am J Physiol Gastrointest Liver Physiol; 2008 Dec; 295(6):G1211-6. PubMed ID: 18845576
[TBL] [Abstract][Full Text] [Related]
13. Organic Cation Transporter 1 Is Responsible for Hepatocellular Uptake of the Tyrosine Kinase Inhibitor Pazopanib.
Ellawatty WEA; Masuo Y; Fujita KI; Yamazaki E; Ishida H; Arakawa H; Nakamichi N; Abdelwahed R; Sasaki Y; Kato Y
Drug Metab Dispos; 2018 Jan; 46(1):33-40. PubMed ID: 29089306
[TBL] [Abstract][Full Text] [Related]
14. Emerging Clinical Importance of Hepatic Organic Cation Transporter 1 (OCT1) in Drug Pharmacokinetics, Dynamics, Pharmacogenetic Variability, and Drug Interactions.
Zamek-Gliszczynski MJ; Giacomini KM; Zhang L
Clin Pharmacol Ther; 2018 May; 103(5):758-760. PubMed ID: 29193038
[TBL] [Abstract][Full Text] [Related]
15. Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics.
Shu Y; Brown C; Castro RA; Shi RJ; Lin ET; Owen RP; Sheardown SA; Yue L; Burchard EG; Brett CM; Giacomini KM
Clin Pharmacol Ther; 2008 Feb; 83(2):273-80. PubMed ID: 17609683
[TBL] [Abstract][Full Text] [Related]
16. Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration.
Tzvetkov MV; dos Santos Pereira JN; Meineke I; Saadatmand AR; Stingl JC; Brockmöller J
Biochem Pharmacol; 2013 Sep; 86(5):666-78. PubMed ID: 23835420
[TBL] [Abstract][Full Text] [Related]
17. Expression of organic cation transporter 1 (OCT1): unique patterns of indirect regulation by nuclear receptors and hepatospecific gene regulation.
Hyrsova L; Smutny T; Trejtnar F; Pavek P
Drug Metab Rev; 2016 May; 48(2):139-58. PubMed ID: 27278216
[TBL] [Abstract][Full Text] [Related]
18. Proteomic Analysis of the Developmental Trajectory of Human Hepatic Membrane Transporter Proteins in the First Three Months of Life.
Mooij MG; van de Steeg E; van Rosmalen J; Windster JD; de Koning BA; Vaes WH; van Groen BD; Tibboel D; Wortelboer HM; de Wildt SN
Drug Metab Dispos; 2016 Jul; 44(7):1005-13. PubMed ID: 27103634
[TBL] [Abstract][Full Text] [Related]
19. Octamer transcription factor 1 mediates epithelial-mesenchymal transition in colorectal cancer.
Li Y; Dong M; Kong F; Zhou J
Tumour Biol; 2015 Dec; 36(12):9941-6. PubMed ID: 26178483
[TBL] [Abstract][Full Text] [Related]
20. Human Intestinal PEPT1 Transporter Expression and Localization in Preterm and Term Infants.
Mooij MG; de Koning BE; Lindenbergh-Kortleve DJ; Simons-Oosterhuis Y; van Groen BD; Tibboel D; Samsom JN; de Wildt SN
Drug Metab Dispos; 2016 Jul; 44(7):1014-9. PubMed ID: 27079248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
